In conclusion, our study revealed that both MSI1 and MSI2 are abnormally expressed in hepatocellular carcinoma, but only the abnormal expression of MSI2 was associated with poor prognosis in a large series of hepatocellular carcinoma. Here, MSI2 is linked to hepatocellular carcinoma.